1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.

Source:http://linkedlifedata.com/resource/pubmed/id/15214785

J. Med. Chem. 2004 Jul 1 47 14 3580-90

Download in:

View as

General Info

PMID
15214785